HomeAI · summaries
Storia in 4 fonti
Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine For a Rapidly Spreading Ebola Outbreak - Merck
Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
nature.com
Inside the high-stakes race to develop an Ebola vaccine for an escalating outbreak
The University of Oxford has already vaccinated its first clinical-trial participant. The study’s lead scientist Teresa Lambe tells Nature how they were able to move so fast.
- ·
channelnewsasia.com
Singapore group will develop 'most promising' Ebola vaccine
The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.
